11-62666758-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001043229.2(CSKMT):c.430G>A(p.Asp144Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00000991 in 1,614,056 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001043229.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSKMT | NM_001043229.2 | c.430G>A | p.Asp144Asn | missense_variant | Exon 3 of 3 | ENST00000532971.2 | NP_001036694.1 | |
LBHD1 | NM_024099.5 | c.538+765C>T | intron_variant | Intron 4 of 6 | ENST00000354588.8 | NP_077004.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSKMT | ENST00000532971.2 | c.430G>A | p.Asp144Asn | missense_variant | Exon 3 of 3 | 2 | NM_001043229.2 | ENSP00000431287.1 | ||
LBHD1 | ENST00000354588.8 | c.538+765C>T | intron_variant | Intron 4 of 6 | 1 | NM_024099.5 | ENSP00000346600.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249302Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135308
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727220
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.430G>A (p.D144N) alteration is located in exon 3 (coding exon 2) of the METTL12 gene. This alteration results from a G to A substitution at nucleotide position 430, causing the aspartic acid (D) at amino acid position 144 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at